GENETIC SIMILARITIES BETWEEN LADA, TYPE 1 AND TYPE 2 DIABETES

  1. Camilla Cervin1,
  2. Valeriya Lyssenko1,
  3. Ekaterine Bakhtadze1,
  4. Eero Lindholm1,
  5. Peter Nilsson2,
  6. Tiinamaija Tuomi3,,4,
  7. Corrado M Cilio5 and
  8. Leif Groop (Leif.Groop{at}med.lu.se)1,,3
  1. 1Department of Clinical Sciences – Diabetes & Endocrinology, CRC, Malmö University Hospital, Lund University, Malmö, Sweden
  2. 2Department of Medicine, Malmö University Hospital, Lund University, Malmö, Sweden
  3. 3Department of Medicine, Helsinki University Central Hospital, and Research Program of Molecular Medicine, University of Helsinki, Helsinki, Finland
  4. 4Folkhalsan Research Centre, Helsinki, Finland
  5. 5Department of Clinical Sciences – Cellular Autoimmunity Unit, CRC, Malmö University Hospital, Lund University, Malmö, Sweden

    Abstract

    Aim: LADA is often considered a slowly progressing subtype of type 1 diabetes, although the clinical picture resembles more type 2 diabetes. One way to improve classification is to study whether LADA shares genetic features with type 1 and/or type 2 diabetes.

    Methods/Results: To accomplish this, we studied whether LADA shares variation in the HLA locus, INS VNTR, PTPN22 genes with type 1 or the TCF7L2 gene with type 2 diabetes, in 361 LADA, 718 type 1, 1676 type 2 diabetic patients and 1704 healthy control subjects from Sweden and Finland. LADA showed, compared to type 2 diabetic patients, increased frequency of risk HLA-DQB1 *0201/*0302 genotype (27% vs. 6.9%; p<1x10−6), with similar frequency as to type 1 diabetes (36%). In addition, LADA showed higher frequencies of protective HLA-DQB1 *0602(3)/X than type 1 diabetic patients (8.1% vs. 3.2%, p=0.003). The AA-genotype of rs689, referring to the class I allele in the INS VNTR, as well as the CT/TT-genotypes of rs2476601 in the PTPN22 gene were increased both in T1D (p=3x10−14 and p=1x10−10, respectively) and LADA (p=0.001 and p=0.002), as compared to controls. Notably, the frequency of the type 2 diabetes-associated CT/TT-genotypes of rs7903146 in the TCF7L2 were increased in LADA (52.8%; p=0.03), to the same extent as in type 2 diabetes (54.1%, p=3x10−7), as compared with controls (44.8%) and type 1 diabetes (43.3%).

    Conclusions: LADA shares genetic features with both type 1 (HLA, INS VNTR and PTPN22) and type 2 (TCF7L2) diabetes, which justifies considering LADA as an admixture of the two major types of diabetes.

    Footnotes

      • Received March 2, 2007.
      • Accepted February 14, 2008.